Lyell Immunopharma, Inc.
SEC CIK 1806952 · LYEL · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Seely Lynn | Director · President and CEO | filed 2021 - 2026 |
| Rieflin William JL | Director | filed 2021 - 2026 |
| Brawley Otis W | Director | filed 2021 - 2026 |
| Friedman Cathy | Director | filed 2021 - 2026 |
| Ramachandra Sumant | Director | filed 2024 - 2026 |
| Klausner Richard | Director · Executive Chairman | filed 2021 - 2026 |
| Nabel Elizabeth G | Director | filed 2021 - 2026 |
| Bachleda Mark | Director | filed 2025 - 2026 |
| Nelsen Robert | Director | filed 2021 - 2026 |
| Bishop Hans Edgar | Director | filed 2021 - 2024 |
| Homans Elizabeth | Director · Chief Executive Officer | filed 2021 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hill Stephen J. | Chief Technical Ops. Officer | filed 2021 - 2026 |
| Lee Gary K. | Chief Scientific Officer | filed 2022 - 2026 |
| Bulis Veronica Sanchez | VP, Corporate Controller | filed 2025 - 2026 |
| Shook David | Chief Medical Officer | filed 2025 - 2026 |
| Shah Smital | Chief Fin. and Bus. Officer | filed 2026 - 2026 |
| Meltz Mark A | General Counsel | filed 2025 - 2026 |
| Newton Charles W. | Chief Financial Officer | filed 2021 - 2025 |
| Lang Matthew | Chief Business Officer | filed 2023 - 2025 |
| Thompson Rahsaan | Chief Legal Officer | filed 2022 - 2023 |
| Albertson Tina M. | Chief Medical Officer | filed 2022 - 2023 |
| Turner Heather D | Chief General Counsel | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.